Superdrug

8 days ago

Skinbiotherapeutrics appoints interim CEO and she looks a very credible hire …but

Any suggestion from the denialists that Skinbiotherapeutics (SBTX) might have over egged the extent of the crimes of disgraced prolific liar and fraudster Stuart Ashman and that there might be a kiss and make up are today put to bed with news that Rachel Parsonage has been appointed as interim CEO. She appears to have a cracking CV but..

---

15 days ago

Skinbiotherapeutics – back to the Amazon Reviews ( a deeper dive)

How accurate are the Amazon reviews for the Skinbiotherapeutics (SBTX) psoriasis product which smells like dog fart and tastes worse? It is a valid question as it may have some bearing on renewal rates and thus whether thus business can ever make a profit on an all in costs basis. It has not to date. And has Skins conveyed that message accurately to investors?

---

17 days ago

Superdrug & Skinbiotherapeutics: surely there is some data in? Have you seen the truly shocking Amazon reviews?

On October 6 2025 Skinbiotherapeutics (SBTX) announced that 195 Superdrug stores would be stocking its acne and psoriasis products “imminently” as part of a two year exclusive deal set to expire in June 2027. All well and good.

---

47 days ago

Skinbiotherapeutics – a question from a prolific liar

In an interview with a rodent Stuart Ashman of Skinbiotherapeutics (SBTX) branded me a “prolific liar” without actually evidencing one single lie. Anyhow on the question of prolific liars…

---

83 days ago

Regarding prolific lying: when did Stuart Ashman start being even more honest about how the June placing cash would be spent?

Bearded Geordie poltroon Stuart Ashman says without citing one actual example that I am a “prolific liar.” The overpaid and under-delivering CEO of Skinbiotherapeutics (SBTX) thinks that he always tells the truth. Let’s rewind to June 16th when shareholders were 10% diluted in a £4.2 million placing.

---

88 days ago

Another question for the Skinbiotherapeutics AGM: Superdrug, the rush to discount and the lack of reviews

Unable to sleep last night I checked out the Superdrug website and to have a look at the Skinbiotherapeutics (SBTX) acne and psoriasis products.
Acne sure is a crowded field, Superdrug sells 376 products including the one from Skins. 

---

126 days ago

Skinbiotherapeutics and the rumoured Broker forecasts for Croda

Our in house bien pensant PL appears to have stumbled on forecasts from credible tier 1 brokers for how much revenue Croda (CRDA) will make from sales of the Skinbiotherapeutics (SBTX) product Zenakine. The source of this is, PL says, AI so it may be hogwash but it, perhaps, raises two critical points.

---

144 days ago

Superdrug & Skinbiotherapeutics: better late than never

As you can see below the Skinbiotherapeutics (SBTX) is, several weeks late, now for sale at Superdrug. Whether the returns justify the 10% dilution of the June placing, supposedly to fund this rollout, is uncertain. I doubt it . But at least here should now be sales and cash coming in.

---

168 days ago

Skinbiotherapeutics: not doing itself any favours over the Superdrug release

I am not saying that Stuart Ashman has goofed operationally. But in terms of being transparent with investors he really is clueless and I say that in a spirit of Christian compassion.

---

181 days ago

I realise Stuart Ashman cares only about his bloated pay but what about the Superdrug launch?

The pretext for the June 16 placing by Skinbiotherapeutics (SBTX) conducted before the company ‘fessed that it was going to miss June 30 revenue forecasts by a country mile, was that cash was needed for a new product launch with Superdrug.

---

216 days ago

Skinbiotherapeutics: A reader contacts AIM Regulation and the FCA re inaccurate forecasts

I do not disagree with a word in this email. I have also made my views clear to the regulators. It is abundantly clear that forecasts out there are wrong and that the company and ts house broker knows all about it and is happy to see a false market continue. The reader writes:

---

231 days ago

Doing Kevin Keegan’s job for him: Forecasting Skins sales prize contest and my forecasts

I am not sure what the prize will be but there will be one. Stuart Ashman has said that the research from analyst “Kevin” Keegan at house broker Singer contain errors and we all know the sales numbers are just plain wrong. I will explain my forecasts for the years ending June 30 2025 and 2026 below. The contest is to give your 2026 forecast and as a tie breaker 2025.

---

244 days ago

Just when you thought the Cavendish coverage of Skins was utterly crap… Singers makes you look back to a golden past! Its numbers are all wrong!

The Singer’s initiation note on its corporate client Skinbotherapeutics(SBTX) is a curious piece of fish. For staters Singer’s makes it clear that it will not, under any circumstances, be made available to private investors it is for II’s and City HNWIs only. This is pointless.

---

267 days ago

Two video clips – can anyone explain why Stuart Ashman of Skinbiotherapeutics is not a LIAR?

Today Skinbiotherapeutics (SBTX) has announced that Superdrug is to sell its acne and psoriasis products. That is the good news. But to fund the rollout it has diluted us all by another 10% with a placing. On 16 April CEO Stuart Ashman recorded an Investor Meet video. Here are two clips. Please can anyone explain why he is not now exposed as a 100% lying scumbag?

---